基于糖蛋白的多重免疫层析IgM血清学试验快速诊断产志贺毒素大肠埃希菌O157和O145
该研究开发并评估了首个基于糖蛋白的多重免疫层析试验,检测人血清中针对大肠埃希菌O157和O145脂多糖O-多糖的IgM抗体。回顾性研究显示,O157和O145的诊断灵敏度分别为97.1%和98.9%,两者合并为97.9%;诊断特异性为98.7%,总体特异性97.4%。将粪便培养和stx/Stx检测与LFIA血清学联合后,血性腹泻或HUS病例与STEC感染的关联从22.8%提高到77.2%。
要点
- O157/O145 LFIA检测IgM抗体,灵敏度97.1%–98.9%,特异性97.4%–98.7%。
- 腹泻发生后3天内检出率83%,3天后升至100%。
- 联合粪便培养和stx/Stx检测可将STEC感染关联率从22.8%提高到77.2%。
核心结论
- E. coli O157/O145 LFIA是高度准确且血清特异性的试验,可用于BD或HUS病例中O157和O145感染的早期快速诊断。
研究设计与样本
- 回顾性研究,开发并评估首个基于糖蛋白的多重免疫层析试验,检测人血清中针对O157和O145脂多糖O-多糖的IgM抗体。
主要发现
- O157和O145的诊断灵敏度分别为97.1%和98.9%,两者合并为97.9%。
- O157和O145的诊断特异性为98.7%,总体特异性97.4%。
- 腹泻发生后3天内样本检出率为83%,3天后升至100%。
- 将粪便培养和stx/Stx检测与LFIA血清学联合后,BD或HUS病例与STEC感染的关联从22.8%提高到77.2%。
关键数值与推荐
- O157/O145 LFIA诊断灵敏度:O157为97.1%,O145为98.9%,合并为97.9%。
- O157/O145 LFIA诊断特异性:O157和O145均为98.7%,总体为97.4%。
- 腹泻发生后3天内检出率83%,3天后100%。
- 联合粪便培养和stx/Stx检测与LFIA血清学,STEC感染关联率从22.8%升至77.2%。
临床怎么用
- 该试验可在感染早期检测特异性IgM抗体,适合在儿科急诊实施,以避免延误正确支持或特异性治疗并预防HUS相关并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Shiga toxin-producing Escherichia coli (STEC) are the main etiological agents of hemolytic uremic syndrome (HUS). Good clinical management of STEC infections and HUS depends on early, rapid, and accurate diagnosis. Here, we have developed and evaluated the first multiplex and glycoprotein-based immunochromatographic test for the detection of IgM antibodies against the O-polysaccharide of the lipopolysaccharide of E. coli O157 and O145 in human serum samples. A retrospective study was carried out resulting in a diagnostic sensitivity of the E. coli O157/O145 LFIA (lateral flow immunoassay) of 97.1% and 98.9% for O157 and O145, respectively, and 97.9% for both serogroups. The diagnostic specificity was 98.7% for O157 and O145, and the overall specificity 97.4%. In samples obtained before 3 days after the onset of diarrhea, the detection percentage was 83%, increasing to 100% from 3 days onward. Finally, the association of bloody diarrhea (BD) or HUS cases to an STEC infection increased from 22.8% to 77.2% when stool culture and stx/Stx detection were combined with serology by LFIA. Our results demonstrate that the E. coli O157/O145 LFIA is a highly accurate and serospecific test for the early and rapid diagnosis of E. coli O157 and O145 infections in BD or HUS cases. This test allows the detection of specific IgM antibodies very early in the course of the infection, making it an ideal diagnostic tool to be implemented in pediatric emergencies and, thus, avoid delays in the application of the correct supportive or specific treatment and prevent complications associated with HUS.
引用
- Landivar SM, Melli LJ, Maiztegui C, et al. A novel multiplex and glycoprotein-based immunochromatographic serologic IgM test for the rapid diagnosis of Escherichia coli O157 and O145 causing bloody diarrhea and hemolytic uremic syndrome. J Clin Microbiol. 2024. PMID: 39480070. doi:10.1128/jcm.01003-24
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。